CHICAGO--(BUSINESS WIRE)--Vyaire Medical, Inc., the healthcare industry’s largest pure-play “breathing” company, today announced it has acquired Ciel Medical, Inc., of San Carlos, CA., a medical device company focused on solving unmet needs of medical professionals caring for intubated patients.
Ciel Medical has developed innovative technologies that will strengthen Vyaire’s strategy to offer products that can help reduce the incidence of Ventilator Acquired Pneumonia for ventilated patients. Ventilator Acquired Pneumonia costs the U.S. healthcare system billions of dollars annually and Vyaire is committed to reducing overall costs of care while improving patient outcomes.
Vyaire management sees the acquisition of Ciel Medical as a step toward the company’s stated goal of becoming the global leader in the respiratory care market.
Terms of the transaction were not disclosed.
About Vyaire Medical
Headquartered in Chicago, IL., Vyaire Medical supports and improves the lives of patients with a laser-focus on improving patient outcomes and increasing value for customers. The company was formed in October 2016, to serve healthcare customers with innovative device and service solutions across the respiratory and anesthesia continua of care. Vyaire’s legacy brands have a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, ventilation, and anesthesia delivery & patient monitoring.
From industry-pioneering brands that include Bird, Bear, and Jaeger to respected industry leaders AirLife®, Vital Signs®, Viasys, and many others — Vyaire Medical has nearly 27,000 distinct part numbers recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide.
Learn more at www.Vyaire.com.
